Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
- PMID: 1326433
- DOI: 10.1016/0920-1211(92)90087-a
Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
Abstract
We investigated the effect of zonisamide, a new antiepileptic drug, on voltage-dependent Ca2+ currents in cultured neurons of rat cerebral cortex. Whole-cell voltage-clamp recordings demonstrated at least two distinct voltage-dependent Ca2+ currents: (1) a low-threshold, rapidly inactivating component, T-type Ca2+ current, which is sensitive to 100 microM Ni2+, and (2) a high-threshold, slowly inactivating (long-lasting) component, L-type Ca2+ current. Zonisamide, a new anticonvulsant effective against maximal electroshock (MES) seizures in mice reduced T-type Ca2+ current in a dose-dependent manner. The mean percentage of reduction was 59.5 +/- 7.2% at 500 microM, but zonisamide had no effect on L-type Ca2+ current. A methylated analog of zonisamide, which is ineffective against MES seizures in mice, was tested at a concentration of 500 microM, and reduced neither T-type nor L-type Ca2+ current. These findings suggest that the effects of zonisamide against MES seizures might occur through the reduction of T-type Ca2+ current. Because drugs that are effective against MES seizures are thought to prevent seizure discharge spread, T-type Ca2+ channels could underlie a cellular mechanism of spreading activity in epileptic seizures.
Similar articles
-
Mechanisms of T-type calcium channel blockade by zonisamide.Seizure. 1996 Jun;5(2):115-9. doi: 10.1016/s1059-1311(96)80104-x. Seizure. 1996. PMID: 8795126
-
Activation by zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells.J Pharmacol Exp Ther. 2007 Apr;321(1):98-106. doi: 10.1124/jpet.106.116954. Epub 2007 Jan 25. J Pharmacol Exp Ther. 2007. PMID: 17255467
-
Calcium currents in acutely isolated human neocortical neurons.J Neurophysiol. 1993 May;69(5):1596-606. doi: 10.1152/jn.1993.69.5.1596. J Neurophysiol. 1993. PMID: 8389832
-
Clinical pharmacology and mechanism of action of zonisamide.Clin Neuropharmacol. 2007 Jul-Aug;30(4):230-40. doi: 10.1097/wnf.0b013e3180413d7d. Clin Neuropharmacol. 2007. PMID: 17762320 Review.
-
Zonisamide: chemistry, mechanism of action, and pharmacokinetics.Seizure. 2004 Dec;13 Suppl 1:S5-9; discussion S10. doi: 10.1016/j.seizure.2004.04.016. Seizure. 2004. PMID: 15511691 Review.
Cited by
-
Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets.Front Pharmacol. 2022 Oct 14;13:948412. doi: 10.3389/fphar.2022.948412. eCollection 2022. Front Pharmacol. 2022. PMID: 36313347 Free PMC article. Review.
-
In vivo evaluation of hippocampal anti-oxidant ability of zonisamide in rats.Neurochem Res. 2000 Aug;25(8):1107-11. doi: 10.1023/a:1007622129369. Neurochem Res. 2000. PMID: 11055748
-
The T-type calcium channel as a new therapeutic target for Parkinson's disease.Pflugers Arch. 2014 Apr;466(4):747-55. doi: 10.1007/s00424-014-1466-6. Epub 2014 Feb 18. Pflugers Arch. 2014. PMID: 24531801 Review.
-
Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.Molecules. 2023 Apr 4;28(7):3220. doi: 10.3390/molecules28073220. Molecules. 2023. PMID: 37049983 Free PMC article. Review.
-
Treatment of juvenile myoclonic epilepsy.CNS Neurosci Ther. 2008 Fall;14(3):227-33. doi: 10.1111/j.1527-3458.2008.00046.x. CNS Neurosci Ther. 2008. PMID: 18684236 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
